Literature DB >> 10682989

Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation.

M Watanabe1, Y Oshima, K Emi.   

Abstract

PURPOSE: To describe the resolution of cystoid macular edema associated with vitreomacular separation in a diabetic patient.
METHODS: Case report. A 58-year-old man who had cataract surgery 3 years earlier developed diabetic macular edema after panretinal laser photocoagulation. For a detailed fundus examination, we performed neodymium: YAG (Nd:YAG) laser capsulotomy in the left eye as the initial management.
RESULTS: Two days after the laser capsulotomy, fundus biomicroscopy and B-mode ultrasonography disclosed a vitreomacular separation in the left eye that was not detectable preoperatively. Optical coherence tomography through the macula disclosed a dramatic decrease in the size of intraretinal cystoid spaces with an improvement of visual acuity. Scanning retinal thickness analysis also confirmed the decrease of retinal thickness at the macula with the resolution of cystoid macular edema.
CONCLUSION: Resolution of diabetic macular edema with subsequent visual recovery is potentially associated with the vitreomacular separation in a patient after Nd:YAG laser capsulotomy.

Entities:  

Mesh:

Year:  2000        PMID: 10682989     DOI: 10.1016/s0002-9394(99)00284-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

Review 1.  Diabetic macular edema: what is focal and what is diffuse?

Authors:  David J Browning; Michael M Altaweel; Neil M Bressler; Susan B Bressler; Ingrid U Scott
Journal:  Am J Ophthalmol       Date:  2008-09-05       Impact factor: 5.258

2.  A Quantitative Approach to Predict Differential Effects of Anti-VEGF Treatment on Diffuse and Focal Leakage in Patients with Diabetic Macular Edema: A Pilot Study.

Authors:  Michael J Allingham; Dibyendu Mukherjee; Erin B Lally; Hossein Rabbani; Priyatham S Mettu; Scott W Cousins; Sina Farsiu
Journal:  Transl Vis Sci Technol       Date:  2017-03-21       Impact factor: 3.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.